Morgan Stanley Vitality Portfolio R6 (MSVOX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

6.54

0.00 (0.00%)

Jul 2, 2026, 4:00 PM EST

21.56% (1Y)

Fund Assets	2.29M
Expense Ratio	0.90%
Min. Investment	$10,000,000
Turnover	n/a
Dividend (ttm)	0.16
Dividend Yield	2.45%
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Jun 9, 2026

Previous Close	6.54
YTD Return	0.11%
1-Year Return	24.50%
5-Year Return	n/a
52-Week Low	5.19
52-Week High	6.90
Beta (5Y)	0.97
Holdings	33
Inception Date	Dec 31, 2021

About MSVOX

Morgan Stanley Vitality Portfolio is a U.S.-focused mutual fund that seeks long-term capital appreciation by investing primarily in healthcare companies. The fund targets firms that are engaged in the discovery, development, production, or distribution of healthcare-related products and services, emphasizing those with strong research and development pipelines, sustainable competitive advantages, and robust financial profiles. Its portfolio is conviction-weighted and highly active, often differing significantly from standard healthcare benchmarks, with a concentrated set of holdings dominated by leading biotech, pharmaceutical, and healthcare technology firms. The portfolio’s investment team applies rigorous research to identify innovative companies poised to benefit from advances in healthcare, resulting in notable exposure to biotechnology, pharmaceuticals, and health care technology sectors. The fund’s role in the market is to offer investors access to high-growth potential in the dynamic healthcare industry, endeavoring to outperform broader equity indices through focused stock selection and active management within a vital sector of the economy.

Category Health

Performance Rating Below Average

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol MSVOX

Share Class Class R6

Index Russell 3000 TR

Performance

MSVOX had a total return of 24.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.82%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MSVDX	Class I	0.95%
MSVEX	Class A	1.30%
MSVMX	Class C	2.05%

Top 10 Holdings

49.09% of assets

Name	Symbol	Weight
argenx SE	ARGX	8.03%
Eli Lilly and Company	LLY	7.79%
Ascendis Pharma A/S	ASND	5.48%
Nektar Therapeutics	NKTR	4.75%
Thermo Fisher Scientific Inc.	TMO	4.28%
Align Technology, Inc.	ALGN	4.18%
Enliven Therapeutics, Inc.	ELVN	3.90%
10x Genomics, Inc.	TXG	3.77%
NewAmsterdam Pharma Company N.V.	NAMS	3.57%
Structure Therapeutics Inc.	GPCR	3.36%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 9, 2026	$0.05761	Jun 9, 2026
Dec 11, 2025	$0.10279	Dec 11, 2025
Dec 11, 2024	$0.00773	Dec 11, 2024

Full Dividend History